| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20054561 | HPV | ENSG00000144285.24 | protein_coding | SCN1A | No | No | 6323 | P35498 |
| TVIS44014625 | HTLV-1 | ENSG00000144285.24 | protein_coding | SCN1A | No | No | 6323 | P35498 |
| TVIS44009369 | HTLV-1 | ENSG00000144285.24 | protein_coding | SCN1A | No | No | 6323 | P35498 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SCN1A |
|---|---|
| DrugBank ID | DB00776 |
| Drug Name | Oxcarbazepine |
| Target ID | BE0004901 |
| UniProt ID | Q8IWT1 |
| Regulation Type | inhibitor |
| PubMed IDs | 28842369; 10845729; 12737829 |
| Citations | Thomas AM, Atkinson TJ: Old Friends With New Faces: Are Sodium Channel Blockers the Future of Adjunct Pain Medication Management? J Pain. 2018 Jan;19(1):1-9. doi: 10.1016/j.jpain.2017.08.001. Epub 2017 Aug 24.@@Shorvon S: Oxcarbazepine: a review. Seizure. 2000 Mar;9(2):75-9. doi: 10.1053/seiz.2000.0391.@@Schmidt D, Sachdeo R: Oxcarbazepine for Treatment of Partial Epilepsy: A Review and Recommendations for Clinical Use. Epilepsy Behav. 2000 Dec;1(6):396-405. doi: 10.1006/ebeh.2000.0126. |
| Groups | Approved |
| Direct Classification | Dibenzazepines |
| SMILES | NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2 |
| Pathways | Carbamazepine Metabolism Pathway |
| PharmGKB | PA450732 |
| ChEMBL | CHEMBL1068 |
